MTS109 in Patients With Refractory Autoimmune Diseases

Clinical trial NCT07526350 · RECRUITING

Trial details

NCT number: NCT07526350
Sponsor: Shanghai Changzheng Hospital
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Idiopathic Inflammatory Myopathies Systemic Sclerosis (SSc)ANCA-Associated Vasculitis (AAV)Sjogren's Syndrome (SS)

Start date: 2026-03-24
Primary completion: 2028-04-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.